Merck
MRK
$128.76
Share price
0.94%
Change (1 day)
8.77%
Change (1 year)
Categories
Market capitalization of Merck (MRK)
Market cap: $326.13 Billion
As of May 2024 Merck has a market cap of $326.13 Billion. This makes Merck the world's 28th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Merck from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $326.13 B | 18.05% |
| 2023 | $276.25 B | -1.79% |
| 2022 | $281.30 B | 45.31% |
| 2021 | $193.58 B | -6.46% |
| 2020 | $206.95 B | -10.38% |
| 2019 | $230.92 B | 16.57% |
| 2018 | $198.09 B | 29.22% |
| 2017 | $153.30 B | -5.55% |
| 2016 | $162.31 B | 10.49% |
| 2015 | $146.89 B | -8.86% |
| 2014 | $161.17 B | 10% |
| 2013 | $146.52 B | 18.25% |
| 2012 | $123.91 B | 7.84% |
| 2011 | $114.90 B | 3.45% |
| 2010 | $111.07 B | -2.2% |
| 2009 | $113.57 B | 76.71% |
| 2008 | $64.27 B | -49.09% |
| 2007 | $126.24 B | 33.57% |
| 2006 | $94.51 B | 36.18% |
| 2005 | $69.40 B | -2.22% |
| 2004 | $70.98 B | -30.84% |
| 2003 | $102.64 B | -19.46% |
| 2002 | $127.44 B | -6.04% |
| 2001 | $135.63 B |
End of Day market cap according to different sources
On May 6th, 2024 the market cap of Merck was reported to be:
$323.13 Billion
$323.13 Billion
$323.13 Billion
$323.06 Billion
$322.98 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $358.94 B | 10.06% | 🇺🇸 USA |
 Novartis NVS | $201.91 B | -38.09% | 🇨🇭 Switzerland |
 Pfizer PFE | $159.62 B | -51.06% | 🇺🇸 USA |
 Abbott Laboratories ABT | $184.38 B | -43.46% | 🇺🇸 USA |
 Eli Lilly LLY | $734.26 B | 125.14% | 🇺🇸 USA |
 Amgen AMGN | $161.97 B | -50.33% | 🇺🇸 USA |
 Sanofi SNY | $123.39 B | -62.16% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $89.31 B | -72.62% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $89.87 B | -72.44% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $15.89 B | -95.13% | 🇮🇱 Israel |